With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.

This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.

A biotech startup called Tessera Therapeutics has made a splash with its claims about the trademarked technology. Is the excitement justified?

Tagged for Cleansing Not just the cell's trash and recycling center, the ubiquitin system controls complex cellular pathways with elegant simplicity and precision. By Michele Pagano have always gravitated toward order. I may even take it a bit too far according to friends who liken my office to a museum. However, I like to think it not a compulsion, but a Feng Shui approach to life. With this need for order, I may have been better suited to

Animals with human cells could provide donor organs or help us understand neuropsychiatric disorders.

By Lauren Urban Evolution of science Science is made up of cliques. Throughout Alex Shneider’s career, he has noticed certain people drawn to certain types of science, and certain types of grant proposals always being funded. Shneider, the founder and CEO of Cure Lab, a vaccine biotech based in Massachusetts, came up with a theory to explain why these cliques occur. At first, it wasn’t too popular. Shneider concluded that a certain type

A guide to DNA-encoded libraries for drug discovery

The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.

George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.

Commercial kits use fluorescent beads to probe dozens of cytokines in one reaction.